The study was a collaborative project with SCRMC faculty member and Professor of Biological Engineering, Melissa Skala’s lab.Ĭollege of Engineering SCRMC lab member Samuel Neuman receives 2022 Barry Goldwater Scholarship This novel study was led by Kaivalya Molugu, a recent PhD graduate in biophysics who worked in SCRMC faculty member and College of Engineering Associate Professor, Krishanu Saha’s lab where Molugu was funded through a Stem Cell and Regenerative Graduate fellowship. The study, published in the journal GEN Biotechnology, outlines the new methodology which includes a real-time method for tracking the reprogramming of somatic cells to induce pluripotent stem cells (iPSCs) using micropatterning, label-free imaging, and machine learning. Team of SCRMC researchers help to improve quality control for biomanufacturing stem cellsĪ team of University of Wisconsin-Madison researchers, including members of the Stem Cell and Regenerative Medicine Center (SCRMC), have developed an innovative methodology that can ultimately be used to advance cutting-edge personalized therapies and disease models. The SCRMC and the BTC Institute thank all who attended as well as the sponsors who helped to make this event a success. The conversation continued during the lunch and networking session, with the rapid-fire presenters as well as eighteen other researchers sharing their posters throughout the event hall. Additionally, attendees participated in a rapid-fire poster session that included twelve presentations by graduate and post-doctoral researchers. Throughout the day, virtual and in-person attendees heard from seven of the world’s leading researchers studying stem cell competition.
This year, the symposium focused on stem cell competition, which has important implications for healthy aging and disease states. Co-hosted by the Stem Cell and Regenerative Medicine Center (SCRMC) and the BioPharmaceutical Technology Center Institute (BTC Institute), this annual event highlights the latest advances in stem cell science and technology. On April 20, 2022, more than 260 students and researchers gathered for the 16th Wisconsin Stem Cell Symposium in Madison, Wis. SMPH Hundreds attend 16 th Wisconsin Stem Cell Symposium focusing on stem cell competition Kamp outlines the opportunities, challenges, and the history of stem cell research in his column “Stem Cells and Regenerative Medicine: A long, but promising road” available on page 40 of the spring 2022 Quarterly magazine. While the past two decades have included dramatic advances, there is still much to learn, and clinical trials are just beginning for a variety of degenerative diseases. These cells, which are pluripotent, meaning they can form any cell type and self-renewing, meaning they can grow indefinitely in culture, changed the way diseases are understood and treated. Nearly twenty-five years ago, University of Wisconsin-Madison researcher James Thomson described the first successful derivation of human embryonic stem cells (hESCs). SCRMC Director Tim Kamp pens perspectives piece for Quarterly magazine Progressive neurodegenerative diseases such as Parkinson’s, Huntington’s, and Alzheimer’s disease present many challenges to patients and their families, and researchers like University of Wisconsin-Madison junior Samuel Neuman are using stem cells and regenerative medicine to find a solution.
JWhen age is more than a number: Undergraduate SCRMC lab member Samuel Neuman focuses on regenerative medicine as a way to impede diseases of degeneration and agingĪging is part of the human experience, but not every experience is the same. The project’s multidisciplinary team, which includes Principal Investigator and SCRMC member Krishanu Saha, hope that this research will lead to advancements in the treatment of neurodevelopmental and neurodegenerative disorders like Alzheimer’s and Parkinson’s Disease.
Stem cell treatment center update#
Center Update Team of SCRMC researchers awarded Research Forward grantĪ team of Stem Cell & Regenerative Medicine Center (SCRMC) researchers will investigate cell therapy as a treatment for brain disorders, injuries, and aging thanks to a Research Forward grant.